PATENT CLAIM ANALYSIS

Application Number: 16245459
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "178100"]

Abstract:
The present invention provides compositions of CD180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.

Claim (Index 6):
The composition of  claim 4 , wherein the heterologous polypeptide antigen comprises beta amyloid.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 99.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14426635', '14993917', '13034144', '12776187', '14049563']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7616496369107122
- 35 USC 102 Novelty (BERT): 0.5966633753742354
- Combined Prediction Score: 0.7451510107570646
- Mean Citation Score: 389.976722
- Max Citation Score: 648.49
- Similarity Product: 410.2547637319565

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test